90
Participants
Start Date
September 17, 2024
Primary Completion Date
March 1, 2025
Study Completion Date
March 1, 2025
Hyperbaric prilocaine
Patients will receive 1.5 ml (30 mg) 0.5% hyperbaric prilocaine.
Hyperbaric bupivacaine
Patients will receive 1.5 ml (7.5 mg) 0.5% hyperbaric bupivacaine.
Tanta University, Tanta
Tanta University
OTHER